Related Experiment Videos

Neurologic deterioration in a child with Wilson's disease on penicillamine therapy

Alexander Chandran Paul1, Sneha Varkki, Nisha B Yohannan

  • 1Departments of Child Health, Christian Medical College and Hospital, Vellore 632 004, Tamil Nadu.

Insights

Penicillamine, a standard Wilson's disease treatment, can cause reversible extrapyramidal symptoms in children. This case highlights the need for careful monitoring during penicillamine therapy for pediatric Wilson's disease.

Area of Science:

  • Pediatric Neurology
  • Hepatology
  • Pharmacology

Background:

  • Wilson's disease is a genetic disorder of copper metabolism, primarily affecting the liver and brain.
  • Penicillamine is a chelating agent widely used as a first-line treatment for Wilson's disease in pediatric patients.

Observation:

  • An 8-year-old girl with Wilson's disease and liver involvement presented with new-onset extrapyramidal symptoms.
  • These neurological symptoms emerged after the initiation of penicillamine therapy.

Findings:

  • The extrapyramidal symptoms in the patient resolved completely within 20 hours of discontinuing penicillamine.
  • Upon reintroduction of low-dose penicillamine, the symptoms reappeared within 24 hours, demonstrating a clear drug-induced effect.

Implications:

  • This case underscores the potential for penicillamine to induce reversible extrapyramidal symptoms in pediatric Wilson's disease patients.
  • Clinicians should consider drug-induced movement disorders when evaluating neurological changes in children treated with penicillamine.
  • Careful dose titration and vigilant monitoring are crucial for managing Wilson's disease with penicillamine in children.

Related Concept Videos